Rocket Pharmaceuticals Stock (NASDAQ:RCKT)
Previous Close
$16.98
52W Range
$15.97 - $32.52
50D Avg
$18.20
200D Avg
$22.80
Market Cap
$1.53B
Avg Vol (3M)
$827.19K
Beta
1.09
Div Yield
-
RCKT Company Profile
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; CIEMAT and UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey.
RCKT Performance
Peer Comparison
Ticker | Company |
---|---|
PLRX | Pliant Therapeutics, Inc. |
DYN | Dyne Therapeutics, Inc. |
RVMD | Revolution Medicines, Inc. Warrant |
VRDN | Viridian Therapeutics, Inc. |
MRUS | Merus N.V. |
LRMR | Larimar Therapeutics, Inc. |
DAWN | Day One Biopharmaceuticals, Inc. |
MGTX | MeiraGTx Holdings plc |
STOK | Stoke Therapeutics, Inc. |
STRO | Sutro Biopharma, Inc. |
RGNX | REGENXBIO Inc. |
REPL | Replimune Group, Inc. |
SNDX | Syndax Pharmaceuticals, Inc. |
INZY | Inozyme Pharma, Inc. |
RYTM | Rhythm Pharmaceuticals, Inc. |
PCVX | Vaxcyte, Inc. |
SLDB | Solid Biosciences Inc. |
CYTK | Cytokinetics, Incorporated |
QURE | uniQure N.V. |
MIRM | Mirum Pharmaceuticals, Inc. |